Special Feature: Diagnosis and Treatment of Neuroangiostrongyliasis in Hawai'i
- PMID: 33313517
- PMCID: PMC7726619
Special Feature: Diagnosis and Treatment of Neuroangiostrongyliasis in Hawai'i
Abstract
Angiostrongylus cantonensis is a metastrongylid lungworm of rats with a global distribution and the cause of neuroangiostrongyliasis in humans. In Hawai'i, neuroangiostrongyliasis cases have occurred sporadically since 1960; however, in 2001, the number of cases on Maui and Hawai'i Island began to increase significantly. Since most human treatment trials have been conducted in Thailand, where the disease is usually mild, there is a need to develop treatment protocols for Hawai'i, where there is a broader disease spectrum. In 2018, preliminary guidelines for the diagnosis and treatment of neuroangiostrongyliasis were developed for Hawai'i's physicians. This article summarizes those guidelines and provides additional recommendations for individuals who recently ingested an infected intermediate host.
Keywords: Angiostrongylus cantonensis; eosinophilic meningitis.
©Copyright 2020 by University Health Partners of Hawai‘i (UHP Hawai‘i).
Figures
References
-
- Alicata JE. Angiostrongyliasis cantonensis (Eosinophilic Meningitis): Historical Events in its Recognition as a New Parasitic Disease of Man. J Wash Acad Sci. 1988;78((1)):38–46.
-
- Wallace G, Rosen L. Studies on eosinophilic meningitis. V. Molluscan hosts of Angiostrongylus cantonensis on Pacific Islands. Am J Trop Med Hyg. 1969;18((2)):06–216. - PubMed
-
- Nomura S, Lin PH. First case report of human infection with Haemostrongylus ratti Yokogawa. Taiwan No Ikai. 1945;3:589–592.
-
- Tiernan JR, Prociv P. Eosinophilic meningoencephalitis with permanent sequelae. Med J Aust. 1987;147((6)):294–295. - PubMed
-
- Eamsobhana P. Eosinophilic meningitis caused by Angiostrongylus cantonensis--a neglected disease with escalating importance. Trop Biomed. 2014;31((4)):569–578. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources